References

Unresolved reference

2024 · External reference

Upgrade rate of percutaneously diagnosed pure atypical ductal hyperplasia: systematic review and meta-analysis of 6458 lesions

10.1148/radiol.2019190748 · 2020 · External reference

BI-RADS 3: current and future use of probably benign

10.1007/s40134-018-0266-8 · 2018 · External reference

Development and prospective validation of a risk calculator that predicts a low risk cohort for atypical ductal hyperplasia upstaging to malignancy: evidence for a watch and wait strategy of a high-risk lesion

10.1245/s10434-020-08881-0 · 2020 · External reference

External validation of a pragmatic scoring system for predicting upgrade of atypical ductal hyperplasia at the time of surgery

10.1245/s10434-025-18803-7 · 2026 · External reference

Determination of factors associated with upstage in atypical ductal hyperplasia to identify low-risk patients where active surveillance may be an alternative

10.1245/s10434-024-15041-1 · 2024 · External reference

Risk of breast cancer in selected women with atypical ductal hyperplasia who do not undergo surgical excision

10.1097/sla.0000000000004849 · 2022 · External reference

Active monitoring with or without endocrine therapy for low-risk ductal carcinoma in situ: the COMET randomized clinical trial

10.1001/jama.2024.26698 · 2025 · External reference

10.1158/1940-6207.capr-26-0082 · 2026 · Admitted local publication

Safety of de-escalation of surgical intervention for atypical ductal hyperplasia on percutaneous biopsy: one size does not fit all

10.1016/j.amjsurg.2022.09.044 · 2023 · External reference

Active surveillance of atypical ductal hyperplasia of the breast

10.1016/j.clbc.2023.05.008 · 2023 · External reference

Role of vacuum assisted excision in minimising overtreatment of ductal atypias

10.1016/j.ejrad.2020.109258 · 2020 · External reference